-Brenda M Sandmaier Researcher Activity Profile

Research Author Detailed Information 

Brenda M Sandmaier Publication Rate By Year

Brenda M Sandmaier has published 1 paper(s) in 2002, 6 paper(s) in 2006, 15 paper(s) in 2007, 4 paper(s) in 2008, for a total of 26 research publications in total.

Brenda M Bm Sandmaier Author Information

LAST NAME: sandmaier

FIRST NAME: Brenda M

INITIALS: bm

AFFILIATION:

Papers

Brenda M Sandmaier's Publication Record

1. Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing. Year Published: 2006
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
2. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation. Year Published: 2006
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.
3. Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation. Year Published: 2006
Medical Center, University of Tuebingen, Department of Hematology and Oncology, Tuebingen, Germany.
4. Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning. Year Published: 2006
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-6072, USA.
5. Outcomes with myeloid malignancies. Year Published: 2006
Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, WA 98109, USA.
6. Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives. Year Published: 2007
Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington, USA. bsandmai@fhcrc.org
7. Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma. Year Published: 2007
Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, Seattle, WA 98109, USA. ggeorges@fhcrc.org
8. Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning. Year Published: 2007
9. Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Year Published: 2007
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
10. Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation. Year Published: 2007
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. mmielcar@fhcrc.org
11. Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors. Year Published: 2007
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
12. Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation. Year Published: 2007
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. mmielcar@fhcrc.org
13. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Year Published: 2007
14. Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors. Year Published: 2007
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. mmielcar@fhcrc.org
15. Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Year Published: 2007
16. Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors. Year Published: 2007
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. mmielcar@fhcrc.org
17. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. Year Published: 2008
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, MS D1-100, Seattle, WA 98109, USA.
18. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Year Published: 2007
Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA 98109-1024, USA. msorror@fhcrc.org
19. Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Year Published: 2007
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA. msorror@fhcrc.org
20. Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. Year Published: 2008
Stanford University Medical Center, Stanford, California 94305-5623, USA. glaport@stanford.edu
21. Non-myeloablative transplantation. Year Published: 2002
Fred Hutchinson Cancer Research Center, Seattle, WA 98104, USA.
22. Outcomes with myeloid malignancies. Year Published: 2006
Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, WA 98109, USA.
23. Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Year Published: 2007
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA. msorror@fhcrc.org
24. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. Year Published: 2008
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, MS D1-100, Seattle, WA 98109, USA.
25. Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. Year Published: 2008
Stanford University Medical Center, Stanford, California 94305-5623, USA. glaport@stanford.edu
26. Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma. Year Published: 2007
Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, Seattle, WA 98109, USA. ggeorges@fhcrc.org